The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s1413-86702010000500017 | DOI Listing |
Publication Analysis
Top Keywords
response predictors
8
predictors treatment
8
chronic hepatitis
8
treatment response
8
treatment
4
treatment pegylated
4
pegylated interferon
4
interferon chronic
4
hepatitis clinical
4
clinical epidemiological
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!